These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 36777416)
1. Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn's Disease or Ulcerative Colitis in the United States. Ding Z; Muser E; Izanec J; Lukanova R; Kershaw J; Roughley A Crohns Colitis 360; 2022 Jul; 4(3):otac023. PubMed ID: 36777416 [TBL] [Abstract][Full Text] [Related]
2. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care. Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383 [TBL] [Abstract][Full Text] [Related]
3. Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics. Mandel MD; Bálint A; Lovász BD; Gulácsi L; Strbák B; Golovics PA; Farkas K; Kürti Z; Szilágyi BK; Mohás A; Molnár T; Lakatos PL Eur J Health Econ; 2014 May; 15 Suppl 1():S121-8. PubMed ID: 24832845 [TBL] [Abstract][Full Text] [Related]
4. Poor Patient-Reported Outcomes and Impaired Work Productivity in Patients With Inflammatory Bowel Disease in Remission. Cross RK; Sauk JS; Zhuo J; Harrison RW; Kerti SJ; Emeanuru K; O'Brien J; Ahmad HA; Sreih AG; Nguyen J; Horst SN; Hudesman D Gastro Hep Adv; 2022; 1(6):927-935. PubMed ID: 39131245 [TBL] [Abstract][Full Text] [Related]
5. The Burden of Work Productivity and Activity Impairment in Patients with Psoriasis, Psoriatic Arthritis, Ulcerative Colitis, and Crohn's Disease. Janak JC; Loughlin AM; Moore PC; Lemay CA; Mease PJ; Lebwohl M; Korzenik JR; Cross RK; Hudesman D Dig Dis Sci; 2024 Aug; 69(8):2784-2795. PubMed ID: 38811505 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease-related economic costs due to presenteeism and absenteeism. Rankala R; Mattila K; Voutilainen M; Mustonen A Scand J Gastroenterol; 2021 Jun; 56(6):687-692. PubMed ID: 33826877 [TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan. Yamabe K; Liebert R; Flores N; Pashos CL Clinicoecon Outcomes Res; 2019; 11():221-232. PubMed ID: 30881067 [TBL] [Abstract][Full Text] [Related]
8. Rectal Urgency Among Patients With Ulcerative Colitis or Crohn's Disease: Analyses from a Global Survey. Ha C; Naegeli AN; Lukanova R; Shan M; Wild R; Hennessy F; Jyothi Kommoju U; Potts Bleakman A; Hunter Gibble T Crohns Colitis 360; 2023 Oct; 5(4):otad052. PubMed ID: 37928613 [TBL] [Abstract][Full Text] [Related]
9. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil. Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478 [TBL] [Abstract][Full Text] [Related]
10. Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn's Disease: Results from a Global Survey of Patients and Gastroenterologists. Regueiro M; Hunter T; Lukanova R; Shan M; Wild R; Knight H; Bannikoppa P; Naegeli AN Adv Ther; 2023 Feb; 40(2):474-488. PubMed ID: 36370288 [TBL] [Abstract][Full Text] [Related]
11. The impact of symptom severity on the humanistic and economic burden of inflammatory bowel disease: a real-world data linkage study. Naegeli AN; Balkaran BL; Shan M; Hunter TM; Lee LK; Jairath V Curr Med Res Opin; 2022 Apr; 38(4):541-551. PubMed ID: 35175166 [TBL] [Abstract][Full Text] [Related]
12. Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland. Kawalec P; Stawowczyk E Prz Gastroenterol; 2018; 13(1):61-68. PubMed ID: 29657613 [TBL] [Abstract][Full Text] [Related]
13. The cost of illness analysis of inflammatory bowel disease. Pakdin M; Zarei L; Bagheri Lankarani K; Ghahramani S BMC Gastroenterol; 2023 Jan; 23(1):21. PubMed ID: 36658489 [TBL] [Abstract][Full Text] [Related]
14. Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis. Leong RW; Huang T; Ko Y; Jeon A; Chang J; Kohler F; Kariyawasam V J Crohns Colitis; 2014 Oct; 8(10):1237-45. PubMed ID: 24662396 [TBL] [Abstract][Full Text] [Related]
15. Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain. Targownik L; Dubinsky MC; Steinwurz F; Bushmakin AG; Cappelleri JC; Tai E; Gardiner S; Hur P; Panés J J Crohns Colitis; 2023 Apr; 17(4):513-523. PubMed ID: 36271912 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization. Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382 [TBL] [Abstract][Full Text] [Related]
17. High Disease Burden Drives Indirect Costs in Employed Inflammatory Bowel Disease Patients: The WORK-IBD Study. van Gennep S; Evers SW; Rietdijk ST; Gielen ME; de Boer NKH; Gecse KB; Ponsioen CIJ; Duijvestein M; D'Haens GR; de Boer AGEM; Löwenberg M Inflamm Bowel Dis; 2021 Feb; 27(3):352-363. PubMed ID: 32378704 [TBL] [Abstract][Full Text] [Related]
18. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland. Holko P; Kawalec P; Mossakowska M; Pilc A PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531 [TBL] [Abstract][Full Text] [Related]
19. Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study. Decker B; Tuzil J; Lukas M; Cerna K; Bortlik M; Velackova B; Pilnackova B; Dolezal T Expert Rev Gastroenterol Hepatol; 2023 Jan; 17(1):99-108. PubMed ID: 36537197 [TBL] [Abstract][Full Text] [Related]
20. Burden of Crohn's disease in the United States: long-term healthcare and work-loss related costs. Manceur AM; Ding Z; Muser E; Obando C; Voelker J; Pilon D; Kinkead F; Lafeuille MH; Lefebvre P J Med Econ; 2020 Oct; 23(10):1092-1101. PubMed ID: 32609019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]